Skip to content

enVista® IOL MX60E (REF MXUE2450)Recalls & reported problems

Bausch & Lomb Incorporated · enVista one-piece hydrophobic acrylic intraocular lens +24.50D · Class 3 · Implant

Data updated Oct 13, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 10757770531490), received between Jun 29, 2023 and Jun 29, 2023 — classified as 1 injury.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem1

Patient problems

  • Visual Impairment1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryJun 29, 2023Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    IT WAS REPORTED THAT APPROXIMATELY ONE MONTH AFTER IMPLANTATION OF AN INTRAOCULAR LENS (IOL) INTO THE LEFT EYE, THE PATIENT EXPERIENCED NEGATIVE DYSPHOTOPSIA REPORTING DECREASED PERIPHERAL VISION. APPROXIMATELY ONE MONTH AFTER ONSET OF SYMPTOMS, THE LEFT EYE IOL WAS EXCHANGED WITH A DIFFERENT MODEL IOL. IN THE "SURGEON'S" OPINION THE LIKELY CAUSE OF EVENT IS, "NEGATIVE DYSPHOTOPSIA, WHICH CAN HAPPEN WITH ANY LENS." PATIENT OUTCOME IS GOOD.

    Patient problems: Visual Impairment

    MAUDE report 17229308 ↗

Other intraocular lens devices

All intraocular lens devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page